Biodegradable intraocular implants containing prostamides

Details for Australian Patent Application No. 2005244203 (hide)

Owner Allergan, Inc.

Inventors Hughes, Patrick M.

Agent Davies Collison Cave

Pub. Number AU-B-2005244203

PCT Pub. Number WO2005/110424

Priority 10/837,260 30.04.04 US

Filing date 20 April 2005

Wipo publication date 24 November 2005

Acceptance publication date 11 February 2010

International Classifications

A61K 31/5575 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110424 Priority application(s): WO2005/110424

11 February 2010 Application Accepted

  Published as AU-B-2005244203

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244207-Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity

2005244202-Macromolecule-containing sustained release intraocular implants and related methods